We are proud to announce that Dr. Berta Cillero-Pastor, Principal Investigator at the MERLN Institute for Technology-Inspired Regenerative Medicine and a key member of the CircBioCare team, has been awarded a prestigious grant under the Human Measurement Models (HMM) call for her groundbreaking…
CircBioCare Team participates in EuPA2025
From June 16 to 20, the CircBioCare team participated in EuPA 2025, the annual conference of the European Proteomics Association, hosted this year in Saint-Malo, France. This key event brought together the European proteomics and mass spectrometry community to exchange knowledge, showcase innovations,…
OA Research Day 2025: Advancing Early Detection in Osteoarthritis with CircBioCare
On June 11th, 2025, the CircBioCare team proudly participated in the Osteoarthritis (OA) Research Day in Delft, an event designed to spotlight the multidisciplinary efforts driving osteoarthritis research in the Netherlands. Held at the historic Hotel Arsenaal, the day brought together clinicians, biomedical…
CircBioCare at the NVMS Spring Meeting 2025: Showcasing Advances in Early Osteoarthritis Biomarkers
On May 26th, 2025, the CircBioCare team had the pleasure of participating in the NVMS Spring Meeting at Sanquin Research in Amsterdam. Organised by the Nederlandse Vereniging voor Massaspectrometrie (NVMS), this annual meeting brings together scientists and innovators from across the Netherlands to…
Betzabeth Pereira Honored with 2025 Bruker Empowerment Award for Groundbreaking Research at MERLN Institute
We are thrilled to announce that Betzabeth Pereira, a brilliant researcher at the MERLN Institute, University of Maastricht, and member of the CircBioCare team, has been awarded the prestigious 2025 Bruker Empowerment Award by Females in Mass Spectrometry (FeMS). This accolade celebrates her outstanding contributions to advancing mass spectrometry…
CircBioCare: Pioneering Early Knee OA Diagnosis
We are excited to announce the launch of CircBioCare, an innovative research project dedicated to transforming early knee osteoarthritis (OA) diagnosis and treatment. With OA affecting over 500 million people worldwide, early detection is crucial to slowing disease progression and improving patient outcomes….